Clinical Trial Update: SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SHR6390 in combination with anastrozole as preoperative treatment for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• SHR6390 (SHR6390)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED